INVO Fertility (IVF) Tops Q2 EPS by 105c

INVO Fertility (NASDAQ: IVF) reported Q2 EPS of $0.35, $1.05 better than the analyst estimate of ($0.70). Revenue for the quarter came in at $2.17 million versus the consensus estimate of $2.4 million.

For earnings history and earnings-related data on INVO Fertility (IVF) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Toll Brothers (TOL) call put ratio 2 calls to 1 put with a focus on September and January 175 calls
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30